Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

This story first appeared in the UNAIDS Global AIDS Update 2025 report.

Healio received an APEX award for a 2024 report on the cloudy future of HIV vaccine research in the age of long-acting ...

Conference on HIV Science on July 17 in Kigali, one message echoed with urgency across Africa—and especially in Kenya: the global HIV response is at a turning point. IAS 2025 was not just a conference ...

Whether it is a refusal of care, humiliating comments or disclosure of their status, many people described feeling alienated. Last year, with funds from Expertise France and the help of UNAIDS and ...

I could only feel shocked at first, like the air was knocked out of my body. My first thought was: My life is over. This is ...

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

The Republican-led Senate rescued funding for PEPFAR in a package of spending cuts last month, but the HIV-prevention program ...

Long-acting lenacapavir has been shown to be a promising option for HIV PrEP and is now recommended globally by WHO, with a ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

LONDON — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, ...

Countries worldwide must step up to support the fight against HIV or face the “ticking time bomb” left by the wholesale ...